Haem oxygenase-I and cardiovascular disease: Mechanisms and therapeutic potential

Clinical Science

Volumn 120, Issue 12, 2011, Pages 493-504

  Chan, Kim H ^a,b   Ng, Martin K C ^a,b   Stocker, Roland ^c  

^a ROYAL PRINCE ALFRED HOSPITAL   (Australia)

^b HEART RESEARCH INSTITUTE   (Australia)

^c UNIVERSITY OF SYDNEY   (Australia)

Author keywords

Angiogenesis; Atherosclerosis; Bilirubin; Cardiovascular disease; Haem oxygenase 1 (HO 1); Vascular repair

Indexed keywords

HEME OXYGENASE 1;

ACUTE CORONARY SYNDROME; ANTIINFLAMMATORY ACTIVITY; ANTIOXIDANT ACTIVITY; CARDIOVASCULAR DISEASE; CAUSE OF DEATH; DRUG MECHANISM; DRUG TARGETING; GENE THERAPY; HUMAN; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN TARGETING; REVIEW; ANIMAL; ENZYME INDUCTION; ENZYMOLOGY; INFLAMMATION; METABOLISM;

ANIMALS; CARDIOVASCULAR DISEASES; ENZYME INDUCTION; HEME OXYGENASE-1; HUMANS; INFLAMMATION;

EID: 79952585899     PISSN: 01435221     EISSN: None     Source Type: Journal    
DOI: 10.1042/CS20100508     Document Type: Review

References (99)

1. Tenhunen, R., Marver, H. and Schmid, R. (1968) The enzymatic conversion of heme to bilirubin by microsomal heme oxygenase. Proc. Natl. Acad. Sci. U.S.A. 61, 748-755
2. Dulak, J., Deshane, J., Jozkowicz, A. and Agarwal, A. (2008) Heme oxygenase-1 and carbon monoxide in vascular pathobiology: focus on angiogenesis. Circulation 117, 231-241
3. Loboda, A., Jazwa, A., Grochot-Przeczek, A., Rutkowski, A., Cisowski, J., Agarwal, A., Jozkowicz, A. and Dulak, J. (2008) Heme oxygenase-1 and the vascular bed: from molecular mechanisms to therapeutic opportunities. Antioxid. Redox Signaling 10, 1767-1812
4. Stocker, R. and Perrella, M. (2006) Heme oxygenase-1: a novel drug target for atherosclerotic diseases? Circulation 114, 2178-2189
5. Ryter, S., Alam, J. and Choi, A. (2006) Heme oxygenase-1/carbon monoxide: from basic science to therapeutic applications. Physiol. Rev. 86, 583-650
6. Yachie, A., Niida, Y., Wada, T., Igarashi, N., Kaneda, H., Toma, T., Ohta, K., Kasahara, Y. and Koizumi, S. (1999) Oxidative stress causes enhanced endothelial cell injury in human heme oxygenase-1 deficiency. J. Clin. Invest. 103, 129-135
7. Poss, K. and Tonegawa, S. (1997) Reduced stress defense in heme oxygenase 1-deficient cells. Proc. Natl. Acad. Sci. U.S.A. 94, 10925-10930
8. Schwertner, H., Jackson, W. and Tolan, G. (1994) Association of low serum concentration of bilirubin with increased risk of coronary artery disease. Clin. Chem. 40, 18-23
9. Lin, J., Vitek, L. and Schwertner, H. (2010) Serum bilirubin and genes controlling bilirubin concentrations as biomarkers for cardiovascular disease. Clin. Chem. 56, 1535-1543
10. Grundemar, L. and Ny, L. (1997) Pitfalls using metalloporphyrins in carbon monoxide research. Trends Pharmacol. Sci. 18, 193-195
11. Poss, K. and Tonegawa, S. (1997) Heme oxygenase 1 is required for mammalian iron reutilization. Proc. Natl. Acad. Sci. U.S.A. 94, 10919-10924
12. Yet, S., Layne, M., Liu, X., Chen, Y., Ith, B., Sibinga, N. and Perrella, M. (2003) Absence of heme oxygenase-1 exacerbates atherosclerotic lesion formation and vascular remodeling. FASEB J. 17, 1759-61
13. Deshane, J., Chen, S., Caballero, S., Grochot-Przeczek, A., Was, H., Calzi, S. L., Lach, R., Hock, T., Chen, B., Hill-Kapturczak, N. et al. (2007) Stromal cell-derived factor 1 promotes angiogenesis via a heme oxygenase 1-dependent mechanism. J. Exp. Med. 204, 605-618
14. Grochot-Przeczek, A., Lach, R., Mis, J., Skrzypek, K., Gozdecka, M., Sroczynska, P., Dubiel, M., Rutkowski, A., Kozakowska, M., Zagorska, A. et al. (2009) Heme oxygenase-1 accelerates cutaneous wound healing in mice. PLoS ONE 4, e5803
15. Stocker, R., Yamamoto, Y., McDonagh, A., Glazer, A. and Ames, B. (1987) Bilirubin is an antioxidant of possible physiological importance. Science 235, 1043-1046 (Pubitemid 17049750)
16. Neuzil, J. and Stocker, R. (1994) Free and albumin-bound bilirubin are efficient co-antioxidants for a-tocopherol, inhibiting plasma and low density lipoprotein lipid peroxidation. J. Biol. Chem. 269, 16712-16719
17. Balla, J., Vercellotti, G., Jeney, V., Yachie, A., Varga, Z., Jacob, H., Eaton, J. and Balla, G. (2007) Heme, heme oxygenase, and ferritin: how the vascular endothelium survives (and dies) in an iron-rich environment. Antioxid. Redox Signaling 9, 2119-2137 (Pubitemid 350059014)
18. Dick, P., Schillinger, M., Minar, E., Mlekusch, W., Amighi, J., Sabeti, S., Schlager, O., Raith, M., Endler, G., Mannhalter, C. et al. (2005) Haem oxygenase-1 genotype and cardiovascular adverse events in patients with peripheral artery disease. Eur J. Clin. Invest. 35, 731-737
19. Kaneda, H., Ohno, M., Taguchi, J., Togo, M., Hashimoto, H., Ogasawara, K., Aizawa, T., Ishizaka, N. and Nagai, R. (2002) Heme oxygenase-1 gene promoter polymorphism is associated with coronary artery disease in Japanese patients with coronary risk factors. Arterioscler. Thromb. Vasc. Biol. 22, 1680-5
20. Chen, Y., Chau, L., Lin, M., Chen, L., Yo, M., Chen, J. and Lin, S. (2004) Heme oxygenase-1 gene promotor microsatellite polymorphism is associated with angiographic restenosis after coronary stenting. Eur. Heart J. 25, 39-47
21. Endler, G., Exner, M., Schillinger, M., Marculescu, R., Sunder-Plassmann, R., Raith, M., Jordanova, N., Wojta, J., Mannhalter, C., Wagner, O. and Huber, K. (2004) A microsatellite polymorphism in the heme oxygenase-1 gene promoter is associated with increased bilirubin and HDL levels but not with coronary artery disease. Thromb. Haemostasis 91, 155-161 (Pubitemid 38111232)
22. Tiroch, K., Koch, W., Beckerath, N. v., Kastrati, A. and Schömig, A. (2007) Heme oxygenase-1 gene promoter polymorphism and restenosis following coronary stenting. Eur. Heart J. 28, 968-973
23. Taha, H., Skrzypek, K., Guevara, I., Nigisch, A., Mustafa, S., Grochot-Przeczek, A., Ferdek, P., Was, H., Kotlinowski, J., Kozakowska, M. et al. (2010) Role of heme oxygenase-1 in human endothelial cells lesson from the promoter allelic variants. Arterioscler. Thromb. Vasc. Biol. 30, 1634-1641
24. Cheng, C., Noordeloos, A., Jeney, V., Soares, M., Moll, F., Pasterkamp, G., Serruys, P. and Duckers, H. (2009) Heme oxygenase 1 determines atherosclerotic lesion progression into a vulnerable plaque. Circulation 119, 3017-3027
25. Li, Y., Wang, D., Chen, S., Tan, X., Fang, X., Wu, J., Zhang, G. and Mai, R. (2006) Haem oxygenase-1 expression and coronary heart disease: association between levels of haem oxygenase-1 expression and angiographic morphology as well as the quantity of coronary lesions. Acta Cardiologica 61, 295-300 (Pubitemid 44014239)
26. Kimm, H., Yun, J., Jo, J. and Jee, S. (2009) Low serum bilirubin level as an independent predictor of stroke incidence: a prospective study in Korean men and women. Stroke 40, 3422-3427
27. Erdogan, D., Gullu, H., Yildirim, E., Tok, D., Kirbas, I., Ciftci, O., Baycan, S. and Muderrisoglu, H. (2006) Low serum bilirubin levels are independently and inversely related to impaired flow-mediated vasodilation and increased carotid intima-media thickness in both men and women. Atherosclerosis 184, 431-437 (Pubitemid 43049731)
28. Chen, Y., Chau, L., Chen, J. and Lin, S. (2008) Serum bilirubin and ferritin levels link heme oxygenase-1 gene promoter polymorphism and susceptibility to coronary artery disease in diabetic patients. Diabetes Care 31, 1615-1620
29. Naghavi, M., Libby, P., Falk, E., Casscells, S., Litovsky, S., Rumberger, J. and Badimon, J. (2003) From vulnerable plaque to vulnerable patient a call for new definitions and risk assessment strategies: part I. Circulation 108, 1664-1672 (Pubitemid 37243650)
30. Wang, L., Lee, T., Lee, F., Pai, R. and Chau, L. (1998) Expression of heme oxygenase-1 in atherosclerotic lesions. Am. J. Pathol. 152, 711-720
31. Orozco, L., Kapturczak, M., Barajas, B., Wang, X., Weinstein, M., Wong, J., Deshane, J., Bolisetty, S., Shaposhnik, Z., Shih, D. et al. (2007) Heme oxygenase-1 expression in macrophages plays a beneficial role in atherosclerosis. Circ. Res. 100, 1703-1711
32. Otterbein, L., Bach, F., Alam, J., Soares, M., Lu, H. T., Wysk, M., Davis, R., Flavell, R. and Choi, A. (2000) Carbon monoxide has anti-inflammatory effects involving the mitogen-activated protein kinase pathway. Nat. Med. 6, 422-428
33. Lee, T. and Chau, L. (2002) Heme oxygenase-1 mediates the anti-inflammatory effect of interleukin-10 in mice. Nat. Med. 8, 240-246
34. Kawamura, K., Ishikawa, K., Wada, Y., Kimura, S., Matsumoto, H., Kohro, T., Itabe, H., Kodama, T. and Maruyama, Y. (2005) Bilirubin from heme oxygenase-1 attenuates vascular endothelial activation and dysfunction. Arterioscler. Thromb. Vasc. Biol. 25, 155-160
35. Hayashi, S., Takamiya, R., Yamaguchi, T., Matsumoto, K., Tojo, S., Tamatani, T., Kitajima, M., Makino, N., Ishimura, Y. and Suematsu, M. (1999) Induction of heme oxygenase-1 suppresses venular leukocyte adhesion elicited by oxidative stress. Circ. Res. 85, 663-671
36. Soares, M., Seldon, M., Gregoire, I., Vassilevskaia, T., Berberat, P., Yu, J., Tsui, T. and Bach, F. (2004) Heme oxygenase-1 modulates the expression of adhesion molecules associated with endothelial cell activation. J. Immunol. 172, 3553-3563 (Pubitemid 38337936)
37. Balla, J., Jacob, H., Balla, G., Nath, K., Eaton, J. and Vercellotti, G. (1993) Endothelial-cell heme uptake from heme proteins: induction of sensitization and desensitization to oxidant damage. Proc. Natl. Acad. Sci. U.S.A. 90, 9285-9289
38. Balla, G., Jacob, H., Eaton, J., Belcher, J. and Vercellotti, G. (1991) Hemin: a possible physiological mediator of low density lipoprotein oxidation and endothelial injury. Arterioscler. Thromb. 11, 1700-1711
39. Carew, T., Schwenke, D. and Steinberg, D. (1987) Antiatherogenic effect of probucol unrelated to its hypocholesterolemic effect: evidence that antioxidants in vivo can selectively inhibit low density lipoprotein degradation in macrophage-rich fatty streaks and slow the progression of atherosclerosis in the Watanabe heritable hyperlipidemic rabbit. Proc. Natl. Acad. Sci. U.S.A. 84, 7725-7729
40. Clark, J., Foresti, R., Green, C. and Motterlini, R. (2000) Dynamics of haem oxygenase-1 expression and bilirubin production in cellular protection against oxidative stress. Biochem. J. 348, 615-9 (Pubitemid 30410252)
41. Brouard, S., Otterbein, L., Anrather, J., Tobiasch, E., Bach, F., Choi, A. and Soares, M. (2000) Carbon monoxide generated by heme oxygenase 1 suppresses endothelial cell apoptosis. J. Exp. Med. 192, 1015-1026
42. Thom, S. (1990) Carbon monoxide-mediated brain lipid peroxidation in the rat. J. Appl. Physiol. 68, 997-1003
43. Balla, G., Jacob, H., Balla, J., Rosenberg, M., Nath, K., Apple, F., Eaton, J. and Vercellotti, G. (1992) Ferritin: a cytoprotective antioxidant strategem of endothelium. J. Biol. Chem. 267, 18148-18153
44. Stocker, R. and Keaney, Jr, J. F. (2004) Role of oxidative modifications in atherosclerosis. Physiol. Rev. 84, 1381-1478
45. Shi, W., Haberland, M., Jien, M., Shih, D. and Lusis, A. (2000) Endothelial responses to oxidized lipoproteins determine genetic susceptibility to atherosclerosis in mice. Circulation 102, 75-81 (Pubitemid 30430556)
46. Duckers, H., Boehm, M., True, A., Yet, S., San, H., Park, J., Webb, R., Lee, M., Nable, G. and Nabel, E. (2001) Heme oxygenase-1 protects against vascular constriction and proliferation. Nat. Med. 7, 693-698
47. Tulis, D., Durante, W., Liu, X., Evans, A., Peyton, K. and Schafer, A. (2001) Adenovirus-mediated heme oxygenase-1 gene delivery inhibits injury-induced vascular neointima formation. Circulation 104, 2710-2715 (Pubitemid 33108139)
48. Tulis, D., Durante, W., Peyton, K., Evans, A. and Schafer, A. (2001) Heme oxygenase-1 attenuates vascular remodeling following balloon injury in rat carotid arteries. Atherosclerosis 155, 113-122 (Pubitemid 32167130)
49. Lau, A., Leichtweis, S., Hume, P., Mashima, R., Hou, J., Chaufour, X., Wilkinson, B., Hunt, N., Celermajer, D. and Stocker, R. (2003) Probucol promotes functional reendothelialization in balloon-injured rabbit aortas. Circulation 107, 2031-2036 (Pubitemid 36506079)
50. Deng, Y., Wu, B., Witting, P. and Stocker, R. (2004) Probucol protects against smooth muscle cell proliferation by upregulating heme oxygenase-1. Circulation 110, 1855-1860 (Pubitemid 39299229)
51. Wu, B., Kathir, K., Witting, P., Beck, K., Choy, K., Li, C., Croft, K., Mori, T., Tanous, D., Adams, M., Lau, A. and Stocker, R. (2006) Antioxidants protect from atherosclerosis by a heme oxygenase-1 pathway that is independent of free radical scavenging. J. Exp. Med. 203, 1117-1127
52. Tanous, D., Bräsen, J., Choya, K., Wu, B., Kathira, K., Lau, A., Celermajer, D. and Stocker, R. (2006) Probucol inhibits in-stent thrombosis and neointimal hyperplasia by promoting re-endothelialization. Atherosclerosis 189, 342-349 (Pubitemid 44740298)
53. Morita, T. and Kourembanas, S. (1995) Endothelial cell expression of vasoconstrictors and growth factors is regulated by smooth muscle cell-derived carbon monoxide. J. Clin. Invest. 96, 2676-2682
54. Beck, K., Wu, B., Ni, J., Santiago, F., Malabanan, K., Li, C., Wang, Y., Khachigian, L. and Stocker, R. (2010) Interplay between heme oxygenase-1 and the multifunctional transcription factor Yin Yang 1 in the inhibition of intimal hyperplasia. Circ. Res. 107, 1490-1497
55. Ollinger, R., Bilban, M., Erat, A., Froio, A., McDaid, J., Tyagi, S., Csizmadia, E., Graça-Souza, A., Liloia, A., Soares, M. et al. (2005) Bilirubin: a natural inhibitor of vascular smooth muscle cell proliferation. Circulation 112, 1030-1039 (Pubitemid 41170272)
56. Sylvester, J. and McGowan, C. (1978) The effects of agents that bind to cytochrome P-450 on hypoxic pulmonary vasoconstriction. Circ. Res. 43, 429-437
57. Furchgott, R. and Jothianandan, D. (1991) Endothelium-dependent and -independent vasodilation involving cyclic GMP: relaxation induced by nitric oxide, carbon monoxide and light. Blood Vessels 28, 52-61
58. Stone, J. and Marletta, M. (1994) Soluble guanylate cyclase from bovine lung: activation with nitric oxide and carbon monoxide and spectral characterization of the ferrous and ferric states. Biochemistry 33, 5636-5640 (Pubitemid 24163003)
59. Morita, T., Perrella, M., Lee, M. and Kourembanas, S. (1995) Smooth muscle cell-derived carbon monoxide is a regulator of vascular cGMP. Proc. Natl. Acad. Sci. U.S.A. 92, 1475-1479
60. Hussain, A., Marks, G., Brien, J. and Nakatsu, K. (1997) The soluble guanylyl cyclase inhibitor 1H-[1,2,4]oxadiazolo[4,3-β] quinoxalin-1-one (ODQ) inhibits relaxation of rabbit aortic rings induced by carbon monoxide, nitric oxide, and glyceryl trinitrate. Can. J. Physiol. Pharmacol. 75, 1034-1037
61. Wang, R., Wang, Z. and Wu, L. (1997) Carbon monoxide-induced vasorelaxation and the underlying mechanisms. Br. J. Pharmacol. 121, 927-934
62. Foresti, R., Hammad, J., Clark, J., Johnson, T., Mann, B., Friebe, A., Green, C. and Motterlini, R. (2004) Vasoactive properties of CORM-3, a novel watersoluble carbon monoxide-releasing molecule. Br. J. Pharmacol. 142, 453-60
63. Batzlsperger, C., Achatz, S., Spreng, J., Riegger, G. and Griese, D. (2007) Evidence for a possible inhibitory interaction between the HO-1/CO- and Akt/NO-pathways in human endothelial cells. Cardiovasc. Drugs Ther. 21, 347-355
64. Heiss, E., Schachner, D., Werner, E. and Dirsch, V. (2009) Active NF-E2-related factor (Nrf2) contributes to keep endothelial NO synthase (eNOS) in the coupled state: role of reactive oxygen species (ROS), eNOS and heme oxygenase (HO-1) levels. J. Biol. Chem. 284, 31579-31586
65. Thorup, C., Jones, C., Gross, S., Moore, L. and Goligorsky, M. (1999) Carbon monoxide induces vasodilation and nitric oxide release but suppresses endothelial NOS. Am. J. Physiol. 277, F882-F889
66. Jones, A., Durante, W. and Korthuis, R. (2010) Heme oxygenase-1 deficiency leads to alteration of soluble guanylate cyclase redox regulation. J. Pharmacol. Exp. Ther. 335, 85-91
67. Suzuki, M., Iso-o, N., Takeshita, S., Tsukamoto, K., Mori, I., Sato, T., Ohno, M., Nagai, R. and Ishizaka, N. (2003) Facilitated angiogenesis induced by heme oxygenase-1 gene transfer in a rat model of hindlimb ischemia. Biochem. Biophys. Res. Commun. 302, 138-143
68. Lin, H., Chen, Y., Chang, P., Lee, Y., Yet, S. and Chau, L. (2008) Heme oxygenase-1 promotes neovascularization in ischemic heart by coinduction of VEGF and SDF-1. J. Mol. Cell. Cardiol. 45, 44-55
69. Dulak, J., Józkowicz, A., Foresti, R., Kasza, A., Frick, M., Huk, I., Green, C., Pachinger, O., Weidinger, F. and Motterlini, R. (2002) Heme oxygenase activity modulates vascular endothelial growth factor synthesis in vascular smooth muscle cells. Antioxid. Redox Signaling 4, 229-240 (Pubitemid 34517174)
70. Jazwa, A., Loboda, A., Golda, S., Cisowski, J., Szelag, M., Zagorska, A., Sroczynska, P., Drukala, J., Jozkowicz, A. and Dulak, J. (2006) Effect of heme and heme oxygenase-1 on vascular endothelial growth factor synthesis and angiogenic potency of human keratinocytes. Free Radical Biol. Med. 40, 1250-1263
71. Jozkowicz, A., Huk, I., Nigisch, A., Weigel, G., Dietrich, W., Motterlini, R. and Dulak, J. (2003) Heme oxygenase and angiogenic activity of endothelial cells: stimulation by carbon monoxide and inhibition by tin protoporphyrin-IX. Antioxid. Redox Signaling 5, 155-162 (Pubitemid 36457591)
72. Bussolati, B., Ahmed, A., Pemberton, H., Landis, R., Carlo, F. D., Haskard, D. and Mason, J. (2004) Bifunctional role for VEGF-induced heme oxygenase-1 in vivo: induction of angiogenesis and inhibition of leukocytic infiltration. Blood 103, 761-766
73. Levine, R., Lam, C., Qian, C., Yu, K., Maynard, S., Sachs, B., Sibai, B., Epstein, F., Romero, R., Thadhani, R. and Karumanchi, S. (2006) Soluble endoglin and other circulating antiangiogenic factors in preeclampsia. N. Engl. J. Med. 355, 992-1005
74. Cudmore, M., Ahmad, S., Al-Ani, B., Fujisawa, T., Coxall, H., Chudasama, K., Devey, L., Wigmore, S., Abbas, A., Hewett, P. and Ahmed, A. (2007) Negative regulation of soluble Flt-1 and soluble endoglin release by heme oxygenase-1. Circulation 115, 1789-1797 (Pubitemid 46648616)
75. Yamaguchi, J., Kusano, K., Masuo, O., Kawamoto, A., Silver, M., Murasawa, S., Bosch-Marce, M., Masuda, H., Losordo, D., Isner, J. and Asahara, T. (2003) Stromal cell-derived factor-1 effects on ex vivo expanded endothelial progenitor cell recruitment for ischemic neovascularization. Circulation 107, 1322-1328
76. Asahara, T., Murohara, T., Sullivan, A., Silver, M., van der Zee, R., Li, T., Witzenbichler, B., Schatteman, G. and Isner, J. (1997) Isolation of putative progenitor endothelial cells for angiogenesis. Science 275, 964-967 (Pubitemid 27087709)
77. Tongers, J., Knapp, J., Korf, M., Kempf, T., Limbourg, A., Limbourg, F., Li, Z., Fraccarollo, D., Bauersachs, J., Han, X. et al. (2008) Haeme oxygenase promotes progenitor cell mobilization, neovascularization, and functional recovery after critical hindlimb ischaemia in mice. Cardiovasc. Res. 78, 294-300
78. Turgeon, J., Dussault, S., Haddad, P., Groleau, J., Ménard, C., Michaud, S., Maingrette, F. and Rivard, A. (2010) Probucol and antioxidant vitamins rescue ischemia-induced neovascularization in mice exposed to cigarette smoke: Potential role of endothelial progenitor cells. Atherosclerosis 208, 342-349
79. Wu, B., Midwinter, R., Cassano, C., Beck, K., Wang, Y., Changsiri, D., Gamble, J. and Stocker, R. (2009) Heme oxygenase-1 increases endothelial progenitor cells. Arterioscler. Thromb. Vasc. Biol. 29, 1537-1542
80. Wegiel, B., Gallo, D., Raman, K., Karlsson, J., Ozanich, B., Chin, B., Tzeng, E., Ahmad, S., Ahmed, A., Baty, C. and Otterbein, L. (2010) Nitric oxide-dependent bone marrow progenitor mobilization by carbon monoxide enhances endothelial repair after vascular injury. Circulation 121, 537-548
81. Seiler, C. (2003) The human coronary collateral circulation. Heart 89, 1352-1357
82. Sawayama, Y., Shimizu, C., Maeda, N., Tatsukawa, M., Kinukawa, N., Koyanagi, S., Kashiwagi, S. and Hayashi, J. (2002) Effects of probucol and pravastatin on common carotid atherosclerosis in patients with asymptomatic hypercholesterolemia. J. Am. Coll. Cardiol. 39, 610-616
83. Tardif, J., Gregoire, J., Schwartz, L., Title, L., Laramée, L., Reeves, F., Lespérance, J., Bourassa, M., L'Allier, P., Glass, M. et al. (2003) Effects of AGI-1067 and probucol after percutaneous coronary interventions. Circulation 107, 552-558 (Pubitemid 36176803)
84. Tardif, J., McMurray, J., Klug, E., Small, R., Schumi, J., Choi, J., Cooper, J., Scott, R., Lewis, E., L'Allier, P. and Pfeffer, M. (2008) Effects of succinobucol (AGI-1067) after an acute coronary syndrome: a randomised, double-blind, placebo-controlled trial. Lancet 371, 1761-1768 (Pubitemid 351697951)
85. Gorogawa, S., Kajimoto, Y., Umayahara, Y., Kaneto, H., Watada, H., Kuroda, A., Kawamori, D., Yasuda, T., Matsuhisa, M., Yamasaki, Y. and Hori, M. (2002) Probucol preserves pancreatic β-cell function through reduction of oxidative stress in type 2 diabetes. Diabetes Res. Clin. Pract. 57, 1-10
86. Uehara, Y., Shimizu, H., Sato, N., Shimomura, Y., Mori, M. and Kobayashi, I. (1991) Probucol partially prevents development of diabetes in NOD mice. Diabetes Res. 17, 131-134
87. Duffy, S. and Dart, A. (2008) Novel cardiac therapies and innocent bystanders. Lancet 371, 1726-1728 (Pubitemid 351697933)
88. Scandinavian Simvastatin Survival Study Group (1994) Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S). Lancet 344, 1383-1389
89. Dulak, J. and Jozkowicz, A. (2005) Anti-angiogenic and anti-inflammatory effects of statins: relevance to anti-cancer therapy. Curr. Cancer Drug Targets 5, 579-594 (Pubitemid 41789598)
90. Grosser, N., Hemmerle, A., Berndt, G., Erdmann, K., Hinkelmann, U., Schurger, S., Wijayanti, N., Immenschuh, S. and Schroder, H. (2004) The antioxidant defense protein heme oxygenase 1 is a novel target for statins in endothelial cells. Free Radical Biol. Med. 37, 2064-2071
91. Lee, T., Chang, C., Zhu, Y. and Shyy, J. (2004) Simvastatin induces heme oxygenase-1: a novel mechanism of vessel protection. Circulation 110, 1296-1302 (Pubitemid 39202348)
92. Keech, A., Simes, R. J., Barter, P., Best, J., Scott, R., Taskinen, M. R., Forder, P., Pillai, A., Davis, T., Glasziou, P. et al. (2005) Effects of long-term fenofibrate therapy on cardiovascular events in 9795 people with type 2 diabetes mellitus (the FIELD study): randomised controlled trial. Lancet 366, 1849-1861
93. Tsimihodimos, V., Miltiadous, G., Daskalopoulou, S., Mikhailidis, D. and Elisaf, M. (2005) Fenofibrate: metabolic and pleiotropic effects. Curr. Vasc. Pharmacol. 3, 87-98
94. Krönke, G., Kadl, A., Ikonomu, E., Bluml, S., Furnkranz, A., Sarembock, I., Bochkov, V., Exner, M., Binder, B. and Leitinger, N. (2007) Expression of heme oxygenase-1 in human vascular cells is regulated by peroxisome proliferator-activated receptors. Arterioscler. Thromb. Vasc. Biol. 27, 1276-1282
95. Melo, L., Agrawal, R., Zhang, L., Rezvani, M., Mangi, A., Ehsan, A., Griese, D., Dell'Acqua, G., Mann, M., Oyama, J. et al. (2002) Gene therapy strategy for long-term myocardial protection using adeno-associated virus-mediated delivery of heme oxygenase gene. Circulation 105, 602-607 (Pubitemid 34123435)
96. Tongers, J., Roncalli, J. and Losordo, D. (2008) Therapeutic angiogenesis for critical limb ischemia: microvascular therapies coming of age. Circulation 118, 9-16
97. Dai, W., Hale, S., Martin, B., Kuang, J., Dow, J., Wold, L. and Kloner, R. (2005) Allogeneic mesenchymal stem cell transplantation in postinfarcted rat myocardium: short-and long-term effects. Circulation 112, 214-223 (Pubitemid 40982304)
98. Zhang, S., Lu, S., Ge, J., Guo, J., Chen, P., Li, T., Zhang, P., Jia, Z., Ma, K., Liu, Y. et al. (2005) Increased heme oxygenase-1 expression in infarcted rat hearts following human bone marrow mesenchymal cell transplantation. Microvasc. Res. 69, 64-70
99. Tang, Y., Tang, Y., Zhang, Y., Qian, K., Shen, L. and Phillips, M. (2005) Improved graft mesenchymal stem cell survival in ischemic heart with a hypoxia-regulated heme oxygenase-1 vector. J. Am. Coll. Cardiol. 46, 1339-50